HomeNews

News
57-year-old Pam receives her vaccine as part of the Oxford/Liverpool clinical trial of MERS ChAdOx1 vaccine.

Oxford and Liverpool scientists launch new vaccine trial for Middle East Respiratory Syndrome (MERS)

Health
Medical Sciences
Research
Vaccines
Burkina Faso R21 vaccine regulatory clearance

Oxford R21/Matrix-M™ malaria vaccine receives regulatory clearance for use in Burkina Faso

Health
Malaria
Vaccines
Artist's impression of an HIV virus

African Phase I HIV vaccine trial shows encouraging preliminary results

HIV
Medical Sciences
Research
Vaccines
R21 vaccinations at Tanzania clinical site,Tom Wilkinson, University of Oxford

R21/Matrix-M™ malaria vaccine developed by University of Oxford receives regulatory clearance for use in Ghana

Malaria
Medical Sciences
Research
Vaccines
Close up image of a vaccine dose being prepared from a vial. Image credit: Shutterstock.

£12 million investment for Future Vaccines Manufacturing Hub

Funding
Health
Medical Sciences
Research
Science
Vaccines
Professor Teresa Lambe receives the Irish Abroad award from Irish President Michael D. Higgins - photo by Maxwell Photography

Oxford vaccinologist Teresa Lambe honoured with Irish Abroad award

Awards
Vaccines
Ebola vaccine offers long-lasting immunity

Oxford Ebola vaccine manufactured and shipped in record time by SII

Ebola
Health
Medical Sciences
Vaccines
An illustration that depicts scientists strategising around a drawing of an HIV virus - artwork by Marzia Munafo

EAVI2020: The Quest for an HIV Vaccine

HIV
Research
Vaccines
Artist's impression of an Ebolavirus

Oxford’s Ebola vaccine recommended for deployment against Uganda outbreak

Ebola
Research
Vaccines
Artist's impression of Mycobacterium tuberculosis, the bacteria that causes TB disease

University of Oxford study provides important insights into TB correlates of protection

Research
Vaccines

Pages